Protagonist Therapeutics Inc
(PTGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,765 | -46,426 | -11,655 | 275,188 | 143,514 |
| Depreciation Amortization | -3,740 | -3,660 | -1,481 | -5,980 | -3,756 |
| Accounts receivable | 164,417 | 165,000 | 165,000 | -155,000 | 10,000 |
| Accounts payable and accrued liabilities | 4,030 | 1,612 | 1,237 | 839 | 2,269 |
| Other Working Capital | 148,874 | 120,813 | 124,692 | -122,610 | 45,111 |
| Other Operating Activity | -133,170 | -140,756 | -152,430 | 191,715 | 16,192 |
| Operating Cash Flow | $94,646 | $96,583 | $125,363 | $184,152 | $213,330 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,446 | -1,358 | -545 | -1,355 | -1,045 |
| Purchase Of Investment | -442,311 | -281,194 | -214,040 | -621,702 | -507,293 |
| Sale Of Investment | 345,610 | 242,960 | 120,183 | 323,574 | 217,580 |
| Investing Cash Flow | $-98,147 | $-39,592 | $-94,402 | $-299,483 | $-290,758 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,506 | 14,847 | 11,922 | 26,453 | 22,422 |
| Other Financing Activity | -479 | -479 | -479 | -600 | -600 |
| Financing Cash Flow | $20,027 | $14,368 | $11,443 | $25,853 | $21,822 |
| Beginning Cash Position | 97,474 | 97,474 | 97,474 | 186,952 | 186,952 |
| End Cash Position | 114,000 | 168,833 | 139,878 | 97,474 | 131,346 |
| Net Cash Flow | $16,526 | $71,359 | $42,404 | $-89,478 | $-55,606 |
| Free Cash Flow | |||||
| Operating Cash Flow | 94,646 | 96,583 | 125,363 | 184,152 | 213,330 |
| Capital Expenditure | -1,446 | -1,358 | -545 | -1,355 | -1,045 |
| Free Cash Flow | 93,200 | 95,225 | 124,818 | 182,797 | 212,285 |